Detalhe da pesquisa
1.
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.
Nature
; 629(8011): 443-449, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658754
2.
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.
Cancer Cell
; 28(1): 15-28, 2015 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26175413
3.
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Nat Med
; 21(11): 1318-25, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479923
4.
Hyaluronidase increases electrogene transfer efficiency in skeletal muscle.
Hum Gene Ther
; 13(3): 355-65, 2002 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-11860703
5.
JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.
Clin Cancer Res
; 19(22): 6230-41, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081976
6.
Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
J Gene Med
; 9(10): 862-74, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17685494